Vir Biotechnology, Inc. VIR Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s change in lease liabilities?
- Vir Biotechnology, Inc. (VIR) reported change in lease liabilities of -$2.27M in Q1 2026.
- How has Vir Biotechnology, Inc.'s change in lease liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s change in lease liabilities decreased by 26.6% year-over-year, from -$1.8M to -$2.27M.
- What is the long-term trend for Vir Biotechnology, Inc.'s change in lease liabilities?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s change in lease liabilities has grown at a 92.6% compound annual growth rate (CAGR), from -$535K to -$7.37M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.